HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James Wangi Selected Research

Neglected Diseases

1/2022Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James Wangi Research Topics

Disease

4Yaws
10/2020 - 12/2017
2Filarial Elephantiasis (Lymphatic Filariasis)
01/2022 - 01/2022
1Neglected Diseases
01/2022
1Infections
01/2018
1Trachoma
01/2018

Drug/Important Bio-Agent (IBA)

5Azithromycin (Zithromax)FDA LinkGeneric
01/2022 - 12/2017
3Ivermectin (Mectizan)FDA Link
01/2022 - 01/2022
3Diethylcarbamazine (Hetrazan)FDA Link
01/2022 - 01/2022
3Albendazole (Albenza)FDA Link
01/2022 - 01/2022
2ReaginsIBA
01/2018 - 12/2017
1AntigensIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2018
123S Ribosomal RNAIBA
01/2018
1AntibodiesIBA
01/2018

Therapy/Procedure

4Mass Drug Administration
01/2022 - 12/2017